AU2001257613A1 - Compositions comprising carriers and transportable complexes - Google Patents

Compositions comprising carriers and transportable complexes

Info

Publication number
AU2001257613A1
AU2001257613A1 AU2001257613A AU5761301A AU2001257613A1 AU 2001257613 A1 AU2001257613 A1 AU 2001257613A1 AU 2001257613 A AU2001257613 A AU 2001257613A AU 5761301 A AU5761301 A AU 5761301A AU 2001257613 A1 AU2001257613 A1 AU 2001257613A1
Authority
AU
Australia
Prior art keywords
carriers
compositions
transportable
complexes
transportable complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257613A
Inventor
L.L. Houston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizeke Pharmaceuticals Inc
Original Assignee
Arizeke Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizeke Pharmaceuticals Inc filed Critical Arizeke Pharmaceuticals Inc
Publication of AU2001257613A1 publication Critical patent/AU2001257613A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
AU2001257613A 2000-04-23 2001-04-19 Compositions comprising carriers and transportable complexes Abandoned AU2001257613A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19942300P 2000-04-23 2000-04-23
US60/199,423 2000-04-23
PCT/US2001/040567 WO2001082972A2 (en) 2000-04-23 2001-04-19 Compositions comprising carriers and transportable complexes

Publications (1)

Publication Number Publication Date
AU2001257613A1 true AU2001257613A1 (en) 2001-11-12

Family

ID=22737432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001257613A Abandoned AU2001257613A1 (en) 2000-04-23 2001-04-19 Compositions comprising carriers and transportable complexes

Country Status (3)

Country Link
US (1) US20020136732A1 (en)
AU (1) AU2001257613A1 (en)
WO (1) WO2001082972A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030161809A1 (en) * 2000-10-02 2003-08-28 Houston L. L. Compositions and methods for the transport of biologically active agents across cellular barriers
CA2522700A1 (en) * 2003-04-18 2004-11-04 Cytovia, Inc. Methods of treating diseases responsive to induction of apoptosis and screening assays
WO2006073446A2 (en) * 2004-04-28 2006-07-13 The Trustees Of The University Of Pennsylvania Peptide-mediated protein transduction into cells the hematopoietic lineage
US8017152B2 (en) * 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
SI2646470T1 (en) 2010-11-30 2017-05-31 F. Hoffmann-La Roche Ag Low affinity anti-transferrin receptor antibodies and their use to transfer therapeutic scfv across the blood brain barrier

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS6098823A (en) * 1983-11-02 1985-06-01 株式会社東芝 Power converter
US4895724A (en) * 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
EP0238645A1 (en) * 1985-10-03 1987-09-30 Biotechnology Research Partners, Ltd. Novel lipoprotein-based drug-delivery systems
US5084441A (en) * 1987-03-04 1992-01-28 Shaw Jack M Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5182258A (en) * 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
US5278142A (en) * 1989-03-20 1994-01-11 Orbon Corporation Systemic delivery of polypeptides through the eye
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
WO1995003035A1 (en) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Polymerized liposomes with enhanced stability for oral delivery
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US6030613A (en) * 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6086875A (en) * 1995-01-17 2000-07-11 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of immunogens
US6485726B1 (en) * 1995-01-17 2002-11-26 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6072041A (en) * 1996-06-03 2000-06-06 Case Western Reserve University Fusion proteins for protein delivery
AU728587B2 (en) * 1996-06-04 2001-01-11 Regents Of The University Of California, The Cellular internalization of pIgR stalk and associated ligands
CA2265587C (en) * 1996-09-06 2004-11-23 Medarex, Inc. Cyanidin compositions and therapeutic and diagnostic uses therefor
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6022734A (en) * 1998-03-07 2000-02-08 Wardlaw Partners, L.P. Disposable apparatus for determining antibiotic sensitivity of bacteria

Also Published As

Publication number Publication date
WO2001082972A2 (en) 2001-11-08
WO2001082972A3 (en) 2003-01-16
US20020136732A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001294192A1 (en) Solid preparations
AUPQ419099A0 (en) Novel compositions and methods
AU2001273569A1 (en) Perfluoropolyethers and processes therefor and therewith
AU2001253418A1 (en) Compounds and methods
AU4657001A (en) Displacing arrangement
AU2001232841A1 (en) Bore-resistant digital goods configuration and distribution methods and arrangements
AU2002211717A1 (en) Stresscopins and their uses
IL152978A0 (en) Macromolecular drug complexes and compositions containing the same
AU2002220419A1 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2001236716A1 (en) Antigenic complexes and methods
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1152601A (en) Compositions and their use
AU2001257613A1 (en) Compositions comprising carriers and transportable complexes
AU2001271400A1 (en) Bioelastomer nanomachines and biosensors
AU2001288102A1 (en) Solid preparations
AU2001240024A1 (en) Camptothecin complexes
AU4432001A (en) Trityl-type compounds and their use
AU2001282521A1 (en) OCT preparations
AU2001272427A1 (en) Solid preparations
AU8252101A (en) Oct preparations
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU5979300A (en) Angiopoietin-6 and uses thereof